Fortuna Helix

Fortuna Helix analyzes an individual’s genetic predisposition to disease development and health traits using advanced polygenic risk modeling. Our flagship Disease Prediction Program evaluates over 3.9 million SNPs to assess risk across up to 37 diseases, supporting earlier intervention and personalized prevention. Our Genetic Health Indicators (GHI) Report provides polygenic insights across physical, physiological, biochemical, and mental health traits, alongside targeted programs for adult obesity risk and adult height potential. Fortuna Helix partners with digital health platforms and healthcare organizations to deliver actionable, scalable genomic intelligence.